베체트 장염의 치료

Behcet`s disease is a chronic relapsing disease with unknown etiology, involving the multiorgan system characterized clinically by oral and genital aphthae, cutaneous lesions, and ophthalmologic, neurologic, or gastrointestinal manifestations (or some combination of these). Since intestinal Behcet`s...

Full description

Saved in:
Bibliographic Details
Published inJournal of rheumatic diseases Vol. 21; no. 4; pp. 176 - 181
Main Authors 김경조, Kyung Jo Kim
Format Journal Article
LanguageKorean
Published 대한류마티스학회 30.08.2014
Subjects
Behcet`s disease
Intestine
내과학
Online AccessGet full text
ISSN2093-940X
2233-4718

Cover

More Information
Summary:Behcet`s disease is a chronic relapsing disease with unknown etiology, involving the multiorgan system characterized clinically by oral and genital aphthae, cutaneous lesions, and ophthalmologic, neurologic, or gastrointestinal manifestations (or some combination of these). Since intestinal Behcet`s disease has been treated anecdotally with various therapeutic modalities, clinical evidence regarding the management of intestinal Behcet`s disease is still lacking. 5-aminosalycylic acid, corticosteroids, immunosuppressants, and surgical therapy have been considered as traditional therapies for intestinal Behcet`s disease. The treatment with thalidomide and anti-TNF agents, such as infliximab or adalimumab, is increasing. Future clinical trials are still needed.
Bibliography:The Korean Rheumatism Association
G704-001068.2014.21.4.009
ISSN:2093-940X
2233-4718